Encepur Adults
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Encepur Adults, covering 2024-03-28 to 2024-03-28. Get the full timeline:
Most recent: Clinical Trial Update: The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine [Phase 4]